Skip to main content
Premium Trial:

Request an Annual Quote

Lung Cancer Screening Study at UCMC to Utilize Precipio ICE-COLD PCR Tech

NEW YORK (GenomeWeb) — Precipio said today that the University of Cincinnati Medical Center (UCMC) will use its ICE-COLD PCR (ICP) mutation enrichment technology in a study screening for clinically actionable mutations in non-small cell lung cancer (NSCLC) patients.

Precipio's ICP is a non-allele-specific mutation multiplexed enrichment technology that can be used on any downstream DNA sequencing platform and on any sample type. According to the New Haven, Connecticut-based Precipio, ICP's ultra-high sensitivity allows for comprehensive genomic analyses to be done using liquid biopsies.

In the study, UCMC researchers will use ICP and high resolution melt (HRM) analysis to screen blood samples from 20 NSCLC patients for actionable mutations in the epidermal growth factor receptor (EGFR) gene. Patients found to be positive for an EGFR mutation will have their ICP-enriched sample tested for two key resistance mutations — T790M and C797S — via real-time PCR.

Results of the study are expected to be submitted for peer-reviewed publication, Precipio said. Pending the outcome of the study, UCMC intends to offer the assays in a clinical setting.

"ICP utilized with HRM enables the early identification of patients with and without these mutations in NSCLC and is crucial to selecting the correct targeted therapy to help treat NSCLC," Precipio Chief Commercial Officer Stephen Miller said in a statement. "We look forward to collaborating with prestigious academic institutions like the University of Cincinnati to research new technologies and generate data through innovative studies and corresponding publications that further validate ICP."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.